Monitoring & Evaluation

Nora Monnier

Dr Nora Monnier is a board-certified specialist of Internal Medicine (FMH Allgemeine Innere Medizin) and Tropical Medicine and Travel Medicine (FMH Tropen- und Reisemedizin) and holds a MSc in Tropical Medicine and International Health from LSHTM, a Diploma for Tropical Medicine and Hygiene (DTMH) from Mahidol University, Bangkok and a Doctor of Medicine degree from University of Zurich. She has 15 years of professional clinical experience including work in low- and middle-income countries (LMICs)and internationally-renowned institutions such as the International Centre for Diarrhoeal Diseases Research (icddr,b) in Dhaka, Bangladesh. Prior to joining Swiss TPH, Nora worked as a consultant in the High Threat Pathogens Unit, Health Emergencies Program at the World Health Organization in Geneva, advising on the guidance of Zika and related flaviviruses laboratory diagnostics. Her expertise includes the epidemiology, clinical management, control and prevention of communicable and non-communicable diseases in the context of LMICs. Her work focuses on NTDs and other tropical diseases, applied communicable disease control and implementation research and projects designing clinical decision support tools for strengthening primary health care in settings of conflict and crisis. Her role and responsibilities in the ADOPT program include project planning, M&E, data management and coordination.  

Eveline Hürlimann

Eveline Hürlimann, trained in biology (BSc) and epidemiology (MSc and PhD) at the University of Basel, Switzerland assists the team of Swiss TPH within the monitoring and evaluation work package of the ADOPT programme. She has more than 10 years of experience in helminth epidemiology and control (mainly soil-transmitted helminths and schistosomiasis). For the past 5 years, Eveline has been involved in clinical trial conduct against helminthic diseases in African and Asian low- and middle income countries for the Helminth Drug Development Unit of Swiss TPH.  

Sammy Njenga

Prof. Sammy M. Njenga is a Senior Principal Research Scientist at the Kenya Medical Research Institute (KEMRI) and former Centre Director of the Eastern and Southern Africa Centre of International Parasite Control (ESACIPAC) in KEMRI. He has PhD in Tropical Health Research from the Liverpool School of Tropical Medicine. Prof. Njenga is actively involved in conducting research on neglected tropical diseases (NTDs) and has contributed to more than 100 articles in peer-reviewed scientific journals. He also holds a visiting professor position in the Department of Parasitology of Nagasaki University, Japan. 

Prof. Njenga has provided technical assistance to NTD programmes in several countries in the African region particularly in monitoring and evaluation (M&E). He is a member of the national NTD Expert Committee and the current national chairperson of the Lymphatic Filariasis Technical Advisory Group (LF TAG). He is also a member of the World Health Organization NTD Diagnostics Technical Advisory Group (DTAG). 

Prof. Njenga is the principal investigator of the ADOPT project in Kenya, leading the M&E work package.

Eliezer N’Goran

Prof. Dr. Eliézer K. N’Goran is from the Université Félix Houphouët Boigny-Abidjan in Côte d’Ivoire. He is currently the head of the department of Zoology and animal Biology and the unit of parasitology, and parasite ecology in the Biosciences faculty. Since the 1990 he activly pursue research, teaching and training. The main activities of his group are epidemiology, ecology, clinical research on drug effectiveness and efficiency and public health issues of human schistosomiasis and geohelminthiases, but also focusses on participating in clinical trials in Côte d’Ivoire. He has published more than 100 manuscripts, original articles and reviews on schistosomiasis research.

Fred Nuwaha

Dr. Fred Nuwaha is a professor of Disease Control and Prevention at Makerere University School of Public Health in Uganda. He has a Bachelor of Medicine and Bachelor of Surgery from Makerere University, a Master’s in Public Health from Leeds University, and a PhD in Disease Control from Karolinsika Institute. His fields of specialty and research interests include Non-Communicable Diseases (NCDs), Neglected Tropical Diseases (NTDs), HIV/STIs, TB, and Malaria; with over 100 peer reviewed publications. He is the Principal Investigator (PI) for FibroSCHoT that is evaluating the impact of repeated doses of praziquantel in Schistosomiasis hot spots in Uganda and a co-PI for SPICES-Scaling-up Packages of Interventions for Cardiovascular disease prevention in selected sites in Europe and Sub-Saharan Africa. In addition, Dr. Nuwaha serves as the chairman for the Ugandan Ministry of Health Expert Committee for Schistosomiasis and Soil Transmitted Helminths, a member of the infectious disease institute scientific review committee, and the associate editor for BMC Public Health.